179 related articles for article (PubMed ID: 37499841)
1. The serum steroid signature of PCOS hints at the involvement of novel pathways for excess androgen biosynthesis.
Altinkilic EM; du Toit T; Sakin Ö; Attar R; Groessl M; Flück CE
J Steroid Biochem Mol Biol; 2023 Oct; 233():106366. PubMed ID: 37499841
[TBL] [Abstract][Full Text] [Related]
2. 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
O'Reilly MW; Kempegowda P; Jenkinson C; Taylor AE; Quanson JL; Storbeck KH; Arlt W
J Clin Endocrinol Metab; 2017 Mar; 102(3):840-848. PubMed ID: 27901631
[TBL] [Abstract][Full Text] [Related]
3. Back where it belongs: 11β-hydroxyandrostenedione compels the re-assessment of C11-oxy androgens in steroidogenesis.
Barnard L; du Toit T; Swart AC
Mol Cell Endocrinol; 2021 Apr; 525():111189. PubMed ID: 33539964
[TBL] [Abstract][Full Text] [Related]
4. The 11β-hydroxyandrostenedione pathway and C11-oxy C
du Toit T; Swart AC
J Steroid Biochem Mol Biol; 2020 Feb; 196():105497. PubMed ID: 31626910
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 52 C
du Toit T; van Rooyen D; Stander MA; Atkin SL; Swart AC
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122243. PubMed ID: 32593151
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.
Keefe CC; Goldman MM; Zhang K; Clarke N; Reitz RE; Welt CK
PLoS One; 2014; 9(4):e93805. PubMed ID: 24713888
[TBL] [Abstract][Full Text] [Related]
7. 11-Oxygenated androgens are not secreted by the human ovary: in-vivo data from four different cases of hyperandrogenism.
Auer MK; Hawley JM; Lottspeich C; Bidlingmaier M; Sappl A; Nowotny HF; Tschaidse L; Treitl M; Reincke M; Keevil BG; Reisch N
Eur J Endocrinol; 2022 Dec; 187(6):K47-K53. PubMed ID: 36239921
[TBL] [Abstract][Full Text] [Related]
8. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
[TBL] [Abstract][Full Text] [Related]
9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
10. Excess 11-Oxygenated Androgens in Women With Severe Insulin Resistance Are Mediated by Adrenal Insulin Receptor Signaling.
Walzer D; Turcu AF; Jha S; Abel BS; Auchus RJ; Merke DP; Brown RJ
J Clin Endocrinol Metab; 2022 Aug; 107(9):2626-2635. PubMed ID: 35696182
[TBL] [Abstract][Full Text] [Related]
11. Steroid hormone analysis of adolescents and young women with polycystic ovarian syndrome and adrenocortical dysfunction using UPC
Swart AC; du Toit T; Gourgari E; Kidd M; Keil M; Faucz FR; Stratakis CA
Pediatr Res; 2021 Jan; 89(1):118-126. PubMed ID: 32247282
[TBL] [Abstract][Full Text] [Related]
12. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione.
O'Reilly MW; Taylor AE; Crabtree NJ; Hughes BA; Capper F; Crowley RK; Stewart PM; Tomlinson JW; Arlt W
J Clin Endocrinol Metab; 2014 Mar; 99(3):1027-36. PubMed ID: 24423344
[TBL] [Abstract][Full Text] [Related]
13. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
[TBL] [Abstract][Full Text] [Related]
14. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
15. Adrenal hyperandrogenism is induced by fetal androgen excess in a rhesus monkey model of polycystic ovary syndrome.
Zhou R; Bird IM; Dumesic DA; Abbott DH
J Clin Endocrinol Metab; 2005 Dec; 90(12):6630-7. PubMed ID: 16174719
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
[TBL] [Abstract][Full Text] [Related]
17. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.
Handelsman DJ; Teede HJ; Desai R; Norman RJ; Moran LJ
Hum Reprod; 2017 Feb; 32(2):418-422. PubMed ID: 27999117
[TBL] [Abstract][Full Text] [Related]
18. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
Carmina E; Rosato F; Jannì A; Rizzo M; Longo RA
J Clin Endocrinol Metab; 2006 Jan; 91(1):2-6. PubMed ID: 16263820
[TBL] [Abstract][Full Text] [Related]
19. Clinical Value of Serum Levels of 11-Oxygenated Metabolites of Testosterone in Women With Polycystic Ovary Syndrome.
Tosi F; Villani M; Garofalo S; Faccin G; Bonora E; Fiers T; Kaufman JM; Moghetti P
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2047-e2055. PubMed ID: 34951635
[TBL] [Abstract][Full Text] [Related]
20. Urinary steroid profiling in women hints at a diagnostic signature of the polycystic ovary syndrome: A pilot study considering neglected steroid metabolites.
Dhayat NA; Marti N; Kollmann Z; Troendle A; Bally L; Escher G; Grössl M; Ackermann D; Ponte B; Pruijm M; Müller M; Vogt B; Birkhäuser MH; Bochud M; Flück CE;
PLoS One; 2018; 13(10):e0203903. PubMed ID: 30308019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
